Picture of Virbac SA logo

VIRP — Virbac SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Brief: Virbac Lowers FY Adjusted EBIT Forecast To Between 12% And 13%

July 3 (Reuters) - Virbac SA  VIRB.PA :
    * VIRBAC REASSESSES ITS 2023 GROWTH AND ADJUSTED EBIT1
FORECASTS
    * MOMENTUM OF OUR ACTIVITY REMAINS POSITIVE IN MANY
GEOGRAPHIES
AND WE ALSO REMAIN CONFIDENT ABOUT GROUP'S 2030 FORECASTS THAT
REMAIN UNCHANGED
    * NOW EXPECT 2023 REVENUE GROWTH AT CONSTANT RATES AND SCOPE
WITHIN A RANGE OF BETWEEN 0% AND 4%
    * RATIO OF ADJUSTED EBIT SHOULD NOW CONSOLIDATE WITHIN A
RANGE OF
BETWEEN 12% AND 13% AT CONSTANT EXCHANGE RATES
    * WE CONFIRM OVERALL MARKET GROWTH SLOWDOWN OBSERVED DURING
Q1,
WITH DECREASING VOLUMES IN MANY GEOGRAPHIES WHILE COMPARED TO
2022
    * WE CONFIRM OVERALL MARKET GROWTH SLOWDOWN OBSERVED DURING
Q1,
WITH DECREASING VOLUMES IN MANY GEOGRAPHIES WHILE COMPARED TO
2022
NOT YET ABLE TO PRECISELY MEASURE ALL CONSEQUENCES OF JUNE 19
CYBERATTACK

Source text for Eikon:  ID:nGNEb8vjf 
Further company coverage:  VIRB.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))

Recent news on Virbac SA

See all news